LY294002 induces p53-dependent apoptosis of SGC7901 gastric cancer cells

Chun-gen Xing,Bao-song Zhu,Hui-hui Liu,Fang Lin,Hui-hua Yao,Zhong-qin Liang,Zheng-hong Qin
DOI: https://doi.org/10.1111/j.1745-7254.2008.00770.x
IF: 7.169
2008-01-01
Acta Pharmacologica Sinica
Abstract:Aim: To study the effects of LY294002, an inhibitor of class I phosphatidylinositol 3-kinase (PI3K), on proliferation and apoptosis of SGC7901 gastric cancer cells. Methods: The MTT assay was used to determine the cytotoxic effects of LY294002. Cell cycle distribution was analyzed using flow cytometry and apoptosis was assessed using flow cytometry analysis after staining DNA with propidium iodide. Mitochondrial membrane potential was measured using the fluorescent probe JC-1. Expression of p53 and PUMA was determined using real-time RT-PCR and Western blotting analysis. Results: The viability of SGC7901 cells was significantly reduced by LY294002 treatment. Expression of p53 and PUMA was induced, and mitochondrial membrane potential collapsed after treatment with LY294002. LY294002 induced apoptotic cell death. Conclusion: Activation of the p53 pathway is involved in LY294002-induced SGC7901 cell death.
What problem does this paper attempt to address?